A rare opportunity to buy high-quality antibody specialist bioventix on the cheap

FTSE 250 company has a leading position in its market niche

A whistle-stop tour of new faces, farewells, winners and losers

THE COMPANIES BOOSTING RETURNS TO SHAREHOLDERS

WHO IS WINNING BETWEEN NOVO-NORDISK AND ELI LILLY?

M&A activity continues to ramp up in London

Stocks which have been missed in the M&A mania